Skip to main content
  • LoDoCo2: Colchicine Reduces Risk of Major Cardiovascular Events in Chronic Coronary Disease

    Colchicine reduces the risk of major cardiovascular events in patients with chronic coronary disease, according to results from the LoDoCo2 trial.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details